CORCEPT THERAPEUTICS INC Repayments of Long-Term Debt
CORCEPT THERAPEUTICS INC (CORT) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2020-02-24
- CORCEPT THERAPEUTICS INC repayments of long-term debt for the quarter ending 2018-12-31 was $0.00.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for fiscal 2019 was $0.00.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for fiscal 2017 was $15.13M, a 2.40% increase from fiscal 2016.
- CORCEPT THERAPEUTICS INC repayments of long-term debt for fiscal 2016 was $14.78M, a 60.52% increase from fiscal 2015.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-24 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $0.00 derived: sum of 2 quarters · filed 2018-11-02 | $0.00 10-Q · filed 2018-11-02 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $4.61M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $4.61M derived: sum of 3 quarters · filed 2020-02-24 | $10.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $4.61M derived: sum of 2 quarters · filed 2020-02-24 | $10.30M derived: sum of 3 quarters · filed 2020-02-24 | $15.13M 10-K · filed 2020-02-24 |
| 2017-09-30 | $4.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $10.30M derived: sum of 2 quarters · filed 2018-11-02 | $15.13M 10-Q · filed 2018-11-02 | $19.57M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $5.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $10.52M 10-Q · filed 2018-08-09 | $14.95M derived: sum of 3 quarters · filed 2019-02-26 | $18.99M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $4.83M 10-Q · filed 2018-05-09 | $9.27M derived: sum of 2 quarters · filed 2019-02-26 | $13.30M derived: sum of 3 quarters · filed 2019-02-26 | $16.57M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.47M derived: sum of 2 quarters · filed 2019-02-26 | $11.74M derived: sum of 3 quarters · filed 2019-02-26 | $14.78M 10-K · filed 2019-02-26 |
| 2016-09-30 | $4.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $7.30M derived: sum of 2 quarters · filed 2017-11-03 | $10.35M 10-Q · filed 2017-11-03 | $13.11M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $6.31M 10-Q · filed 2017-08-02 | $9.07M derived: sum of 3 quarters · filed 2018-02-28 | $11.56M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $3.04M 10-Q · filed 2017-05-02 | $5.80M derived: sum of 2 quarters · filed 2018-02-28 | $8.29M derived: sum of 3 quarters · filed 2018-02-28 | $10.38M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $5.25M derived: sum of 2 quarters · filed 2018-02-28 | $7.34M derived: sum of 3 quarters · filed 2018-02-28 | $9.21M 10-K · filed 2018-02-28 |
| 2015-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $4.58M derived: sum of 2 quarters · filed 2016-11-02 | $6.44M 10-Q · filed 2016-11-02 | $8.01M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.95M 10-Q · filed 2016-08-03 | $5.52M derived: sum of 3 quarters · filed 2017-03-06 | $6.80M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $1.86M 10-Q · filed 2016-05-04 | $3.43M derived: sum of 2 quarters · filed 2017-03-06 | $4.71M derived: sum of 3 quarters · filed 2017-03-06 | $5.73M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $2.84M derived: sum of 2 quarters · filed 2017-03-06 | $3.86M derived: sum of 3 quarters · filed 2017-03-06 | $4.86M 10-K · filed 2017-03-06 |
| 2014-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.29M derived: sum of 2 quarters · filed 2015-11-06 | $3.29M 10-Q · filed 2015-11-06 | $3.94M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $2.01M 10-Q · filed 2015-08-07 | $2.66M derived: sum of 3 quarters · filed 2016-03-10 | |
| 2014-03-31 | $995.00K 10-Q · filed 2015-05-08 | $1.64M derived: sum of 2 quarters · filed 2016-03-10 | ||
| 2013-12-31 | $647.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $1.02M 10-K · filed 2016-03-10 | ||
| 2013-09-30 | $378.00K 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |